Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations (original) (raw)

. 1995 Nov;147(5):1398–1407.

Abstract

The normal counterpart of the neoplastic B cells occurring in Burkitt's lymphomas (BL) is an issue of controversial debate. To clarify this matter, a semi-nested primer polymerase chain reaction was performed to amplify the VDJ rearrangements of the immunoglobulin heavy chain (VH) gene of DNA extracts from 10 (8 sporadic and 2 endemic) BL cases. The resulting amplificates were sequenced for comparison with known germ line VH segments. The control cases comprised six cases of B cell chronic lymphocytic leukemia and six cases of mantle cell lymphoma known to display naive nonmutated, ie, pre-germinal center VH configurations; and eight cases of follicular center lymphoma known to display mutated VH genes with signs of a still-ongoing mutation reaction, characteristic for germinal center cells and lymphomas that derive therefrom. The results of this approach revealed that both sporadic and endemic BL express mutated VH genes with a mutation frequency considerably lower (4.9% and 5.4%, respectively) than that observed in follicular center lymphoma (11.8%). In addition, after subcloning the amplificates, sequence analysis revealed no signs of ongoing mutations. These results led us to conclude that the derivation of neoplastic B cells in BL is definitely not from naive, nonmutated pre-germinal center B cells. Instead, our findings support the view that BL cells stem either from early centroblasts that are arrested after an initial hypermutation reaction, or from germinal center B cells that have differentiated in terms of surface immunoglobulin profile and mutation pattern but not in terms of morphology and proliferation toward SIgM+ IgD- memory B cells because of the deregulated c-myc gene expression.

1398

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURKITT D. A sarcoma involving the jaws in African children. Br J Surg. 1958 Nov;46(197):218–223. doi: 10.1002/bjs.18004619704. [DOI] [PubMed] [Google Scholar]
  2. Bakkus M. H., Heirman C., Van Riet I., Van Camp B., Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992 Nov 1;80(9):2326–2335. [PubMed] [Google Scholar]
  3. Berek C., Ziegner M. The maturation of the immune response. Immunol Today. 1993 Aug;14(8):400–404. doi: 10.1016/0167-5699(93)90143-9. [DOI] [PubMed] [Google Scholar]
  4. Berger R., Bernheim A., Brouet J. C., Daniel M. T., Flandrin G. t(8;14) translocation in a Burkitt's type of lymphoblastic leukaemia (L3). Br J Haematol. 1979 Sep;43(1):87–90. doi: 10.1111/j.1365-2141.1979.tb03723.x. [DOI] [PubMed] [Google Scholar]
  5. Bird J., Galili N., Link M., Stites D., Sklar J. Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med. 1988 Jul 1;168(1):229–245. doi: 10.1084/jem.168.1.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang B., Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today. 1994 Aug;15(8):367–373. doi: 10.1016/0167-5699(94)90175-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cook W. D., Scharff M. D. Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5687–5691. doi: 10.1073/pnas.74.12.5687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DORFMAN R. F. CHILDHOOD LYMPHOSARCOMA IN ST. LOUIS, MISSOURI, CLINICALLY AND HISTOLOGICALLY RESEMBLING BURKITT'S TUMOR. Cancer. 1965 Apr;18:418–430. doi: 10.1002/1097-0142(196504)18:4<418::aid-cncr2820180404>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Drexler H. G., Messmore H. L., Menon M., Minowada J. A case of TdT-positive B-cell acute lymphoblastic leukemia. Am J Clin Pathol. 1986 Jun;85(6):735–738. doi: 10.1093/ajcp/85.6.735. [DOI] [PubMed] [Google Scholar]
  10. Flandrin G., Brouet J. C., Daniel M. T., Preud'homme J. L. Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood. 1975 Feb;45(2):183–188. [PubMed] [Google Scholar]
  11. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  12. Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood. 1994 Jul 15;84(2):403–407. [PubMed] [Google Scholar]
  13. Jukes T. H., King J. L. Evolutionary nucleotide replacements in DNA. Nature. 1979 Oct 18;281(5732):605–606. doi: 10.1038/281605a0. [DOI] [PubMed] [Google Scholar]
  14. Kepler T. B., Perelson A. S. Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. Immunol Today. 1993 Aug;14(8):412–415. doi: 10.1016/0167-5699(93)90145-B. [DOI] [PubMed] [Google Scholar]
  15. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. Surgace IgM specificity on cells derived from a Burkitt's lymphoma. Lancet. 1967 Nov 18;2(7525):1068–1070. doi: 10.1016/s0140-6736(67)90340-6. [DOI] [PubMed] [Google Scholar]
  16. Klein U., Küppers R., Rajewsky K. Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol. 1993 Dec;23(12):3272–3277. doi: 10.1002/eji.1830231232. [DOI] [PubMed] [Google Scholar]
  17. Kocks C., Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu Rev Immunol. 1989;7:537–559. doi: 10.1146/annurev.iy.07.040189.002541. [DOI] [PubMed] [Google Scholar]
  18. Kraal G., Weissman I. L., Butcher E. C. Germinal centre B cells: antigen specificity and changes in heavy chain class expression. Nature. 1982 Jul 22;298(5872):377–379. doi: 10.1038/298377a0. [DOI] [PubMed] [Google Scholar]
  19. Küppers R., Gause A., Rajewsky K. B cells of chronic lymphatic leukemia express V genes in unmutated form. Leuk Res. 1991;15(6):487–496. doi: 10.1016/0145-2126(91)90060-7. [DOI] [PubMed] [Google Scholar]
  20. Küppers R., Zhao M., Hansmann M. L., Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993 Dec 15;12(13):4955–4967. doi: 10.1002/j.1460-2075.1993.tb06189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levy R., Levy S., Cleary M. L., Carroll W., Kon S., Bird J., Sklar J. Somatic mutation in human B-cell tumors. Immunol Rev. 1987 Apr;96:43–58. doi: 10.1111/j.1600-065x.1987.tb00508.x. [DOI] [PubMed] [Google Scholar]
  22. MacLennan I. C., Liu Y. J., Johnson G. D. Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immunol Rev. 1992 Apr;126:143–161. doi: 10.1111/j.1600-065x.1992.tb00635.x. [DOI] [PubMed] [Google Scholar]
  23. Magrath I. T., Ziegler J. L. Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res. 1980;4(1):33–59. doi: 10.1016/0145-2126(80)90045-4. [DOI] [PubMed] [Google Scholar]
  24. Mann R. B., Jaffe E. S., Braylan R. C., Nanba K., Frank M. M., Ziegler J. L., Berard C. W. Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med. 1976 Sep 23;295(13):685–691. doi: 10.1056/NEJM197609232951301. [DOI] [PubMed] [Google Scholar]
  25. Mitelman F., Andersson-Anvret M., Brandt L., Catovsky D., Klein G., Manolov G., Manolova Y., Mark-Vendel E., Nilsson P. G. Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. Int J Cancer. 1979 Jul 15;24(1):27–33. doi: 10.1002/ijc.2910240106. [DOI] [PubMed] [Google Scholar]
  26. Nudelman E., Kannagi R., Hakomori S., Parsons M., Lipinski M., Wiels J., Fellous M., Tursz T. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science. 1983 Apr 29;220(4596):509–511. doi: 10.1126/science.6836295. [DOI] [PubMed] [Google Scholar]
  27. O'CONOR G. T. Malignant lymphoma in African children. II. A pathological entity. Cancer. 1961 Mar-Apr;14:270–283. doi: 10.1002/1097-0142(196103/04)14:2<270::aid-cncr2820140207>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  28. Pratt L. F., Rassenti L., Larrick J., Robbins B., Banks P. M., Kipps T. J. Ig V region gene expression in small lymphocytic lymphoma with little or no somatic hypermutation. J Immunol. 1989 Jul 15;143(2):699–705. [PubMed] [Google Scholar]
  29. Raff M. C., Sternberg M., Taylor R. B. Immunoglobulin determinants on the surface of mouse lymphoid cells. Nature. 1970 Feb 7;225(5232):553–554. doi: 10.1038/225553a0. [DOI] [PubMed] [Google Scholar]
  30. Ritz J., Nadler L. M., Bhan A. K., Notis-McConarty J., Pesando J. M., Schlossman S. F. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood. 1981 Sep;58(3):648–652. [PubMed] [Google Scholar]
  31. Roos G., Nordenson I., Osterman B., Jorpes P., Rudolphi O. Patient with acute B-cell leukemia of Burkitt's type (L3) and marker chromosomes including an (8;14) translocation. Leuk Res. 1982;6(1):27–31. doi: 10.1016/0145-2126(82)90040-6. [DOI] [PubMed] [Google Scholar]
  32. Secker-Walker L., Stewart E., Norton J., Campana D., Thomas A., Hoffbrand V., Prentice G. Multiple chromosome abnormalities in a drug resistant TdT positive B-cell leukemia. Leuk Res. 1987;11(2):155–161. doi: 10.1016/0145-2126(87)90021-x. [DOI] [PubMed] [Google Scholar]
  33. Siskind G. W., Benacerraf B. Cell selection by antigen in the immune response. Adv Immunol. 1969;10:1–50. doi: 10.1016/s0065-2776(08)60414-9. [DOI] [PubMed] [Google Scholar]
  34. Stein H., Gerdes J., Mason D. Y. The normal and malignant germinal centre. Clin Haematol. 1982 Oct;11(3):531–559. [PubMed] [Google Scholar]
  35. Stein H., Lennert K., Feller A. C., Mason D. Y. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res. 1984;42:67–147. doi: 10.1016/s0065-230x(08)60456-x. [DOI] [PubMed] [Google Scholar]
  36. Stiernholm N., Kuzniar B., Berinstein N. L. Absence of immunoglobulin variable region hypermutation in a large cell lymphoma after in vivo and in vitro propagation. Blood. 1992 Aug 1;80(3):738–743. [PubMed] [Google Scholar]
  37. Tamaru J., Hummel M., Zemlin M., Kalvelage B., Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood. 1994 Aug 1;84(3):708–715. [PubMed] [Google Scholar]
  38. Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol. 1992 Oct 5;227(3):776–798. doi: 10.1016/0022-2836(92)90223-7. [DOI] [PubMed] [Google Scholar]
  39. Wagner S. D., Luzzatto L. V kappa gene segments rearranged in chronic lymphocytic leukemia are distributed over a large portion of the V kappa locus and do not show somatic mutation. Eur J Immunol. 1993 Feb;23(2):391–397. doi: 10.1002/eji.1830230214. [DOI] [PubMed] [Google Scholar]
  40. Zelenetz A. D., Chen T. T., Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med. 1992 Oct 1;176(4):1137–1148. doi: 10.1084/jem.176.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]